nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—SLC22A10—Conjugated Estrogens—osteoporosis	0.329	0.41	CbGbCtD
Salicylic acid—PTGS2—Risedronate—osteoporosis	0.0757	0.0942	CbGbCtD
Salicylic acid—SLCO2B1—Conjugated Estrogens—osteoporosis	0.0604	0.0752	CbGbCtD
Salicylic acid—SLCO2B1—Estradiol—osteoporosis	0.053	0.066	CbGbCtD
Salicylic acid—SLC22A11—Conjugated Estrogens—osteoporosis	0.0496	0.0617	CbGbCtD
Salicylic acid—SLC22A11—Estradiol—osteoporosis	0.0435	0.0542	CbGbCtD
Salicylic acid—ALB—Estropipate—osteoporosis	0.0362	0.045	CbGbCtD
Salicylic acid—SLC22A8—Conjugated Estrogens—osteoporosis	0.0288	0.0359	CbGbCtD
Salicylic acid—SLC22A8—Estradiol—osteoporosis	0.0253	0.0315	CbGbCtD
Salicylic acid—SLC22A6—Conjugated Estrogens—osteoporosis	0.0201	0.025	CbGbCtD
Salicylic acid—CYP2C9—Estropipate—osteoporosis	0.0195	0.0243	CbGbCtD
Salicylic acid—ALB—Estradiol—osteoporosis	0.015	0.0187	CbGbCtD
Salicylic acid—ABCB1—Ethinyl Estradiol—osteoporosis	0.0122	0.0152	CbGbCtD
Salicylic acid—CYP2C9—Cholecalciferol—osteoporosis	0.01	0.0125	CbGbCtD
Salicylic acid—ABCB1—Conjugated Estrogens—osteoporosis	0.00895	0.0111	CbGbCtD
Salicylic acid—CYP2C9—Estradiol—osteoporosis	0.00809	0.0101	CbGbCtD
Salicylic acid—ABCB1—Estradiol—osteoporosis	0.00786	0.00977	CbGbCtD
Salicylic acid—Dysgeusia—Calcium Acetate—osteoporosis	0.00109	0.00795	CcSEcCtD
Salicylic acid—Asthma—Etidronic acid—osteoporosis	0.00105	0.00764	CcSEcCtD
Salicylic acid—Oesophagitis—Risedronate—osteoporosis	0.00105	0.00761	CcSEcCtD
Salicylic acid—Ecchymosis—Risedronate—osteoporosis	0.00104	0.00753	CcSEcCtD
Salicylic acid—Abdominal pain upper—Ibandronate—osteoporosis	0.000921	0.0067	CcSEcCtD
Salicylic acid—Confusional state—Calcium Acetate—osteoporosis	0.000918	0.00668	CcSEcCtD
Salicylic acid—Oedema—Calcium Acetate—osteoporosis	0.00091	0.00662	CcSEcCtD
Salicylic acid—Asthma—Estropipate—osteoporosis	0.000909	0.00661	CcSEcCtD
Salicylic acid—Oesophagitis—Zoledronate—osteoporosis	0.000909	0.00661	CcSEcCtD
Salicylic acid—Abdominal pain upper—Calcitriol—osteoporosis	0.000902	0.00656	CcSEcCtD
Salicylic acid—Asthma—Alendronate—osteoporosis	0.000896	0.00651	CcSEcCtD
Salicylic acid—Asthma—Ibandronate—osteoporosis	0.000872	0.00634	CcSEcCtD
Salicylic acid—Abdominal discomfort—Estropipate—osteoporosis	0.000872	0.00634	CcSEcCtD
Salicylic acid—Anorexia—Calcium Acetate—osteoporosis	0.000868	0.00631	CcSEcCtD
Salicylic acid—Abdominal discomfort—Alendronate—osteoporosis	0.000859	0.00624	CcSEcCtD
Salicylic acid—Lightheadedness—Conjugated Estrogens—osteoporosis	0.000857	0.00623	CcSEcCtD
Salicylic acid—Hallucination—Etidronic acid—osteoporosis	0.000837	0.00609	CcSEcCtD
Salicylic acid—Abdominal discomfort—Ibandronate—osteoporosis	0.000836	0.00608	CcSEcCtD
Salicylic acid—Weight increased—Estropipate—osteoporosis	0.000827	0.00602	CcSEcCtD
Salicylic acid—Lethargy—Pamidronate—osteoporosis	0.000806	0.00587	CcSEcCtD
Salicylic acid—Hearing impaired—Estradiol—osteoporosis	0.000805	0.00586	CcSEcCtD
Salicylic acid—Weight increased—Raloxifene—osteoporosis	0.000802	0.00583	CcSEcCtD
Salicylic acid—Erythema multiforme—Etidronic acid—osteoporosis	0.000795	0.00579	CcSEcCtD
Salicylic acid—Decreased appetite—Calcium Acetate—osteoporosis	0.000791	0.00576	CcSEcCtD
Salicylic acid—Pain—Calcium Acetate—osteoporosis	0.000778	0.00566	CcSEcCtD
Salicylic acid—Constipation—Calcium Acetate—osteoporosis	0.000778	0.00566	CcSEcCtD
Salicylic acid—Anorexia—Ergocalciferol—osteoporosis	0.000767	0.00558	CcSEcCtD
Salicylic acid—Drowsiness—Calcitriol—osteoporosis	0.000761	0.00554	CcSEcCtD
Salicylic acid—Abdominal pain upper—Risedronate—osteoporosis	0.000759	0.00552	CcSEcCtD
Salicylic acid—Feeling abnormal—Calcium Acetate—osteoporosis	0.00075	0.00546	CcSEcCtD
Salicylic acid—Lethargy—Zoledronate—osteoporosis	0.000737	0.00536	CcSEcCtD
Salicylic acid—Erythema—Etidronic acid—osteoporosis	0.000732	0.00533	CcSEcCtD
Salicylic acid—Skin exfoliation—Estradiol—osteoporosis	0.000732	0.00532	CcSEcCtD
Salicylic acid—Asthma—Risedronate—osteoporosis	0.000719	0.00523	CcSEcCtD
Salicylic acid—Decreased appetite—Ergocalciferol—osteoporosis	0.000699	0.00508	CcSEcCtD
Salicylic acid—Abdominal discomfort—Risedronate—osteoporosis	0.000689	0.00501	CcSEcCtD
Salicylic acid—Erythema multiforme—Estropipate—osteoporosis	0.000688	0.00501	CcSEcCtD
Salicylic acid—Pain—Ergocalciferol—osteoporosis	0.000688	0.005	CcSEcCtD
Salicylic acid—Constipation—Ergocalciferol—osteoporosis	0.000688	0.005	CcSEcCtD
Salicylic acid—Erythema multiforme—Alendronate—osteoporosis	0.000678	0.00493	CcSEcCtD
Salicylic acid—Weight increased—Ethinyl Estradiol—osteoporosis	0.000671	0.00488	CcSEcCtD
Salicylic acid—Abdominal pain upper—Zoledronate—osteoporosis	0.000659	0.0048	CcSEcCtD
Salicylic acid—Erythema multiforme—Calcitriol—osteoporosis	0.000646	0.0047	CcSEcCtD
Salicylic acid—Pruritus—Calcium Acetate—osteoporosis	0.000644	0.00468	CcSEcCtD
Salicylic acid—Erythema—Estropipate—osteoporosis	0.000634	0.00461	CcSEcCtD
Salicylic acid—Erythema—Alendronate—osteoporosis	0.000624	0.00454	CcSEcCtD
Salicylic acid—Asthma—Zoledronate—osteoporosis	0.000624	0.00454	CcSEcCtD
Salicylic acid—Diarrhoea—Calcium Acetate—osteoporosis	0.000623	0.00453	CcSEcCtD
Salicylic acid—Deafness—Estradiol—osteoporosis	0.000622	0.00452	CcSEcCtD
Salicylic acid—Dysgeusia—Alendronate—osteoporosis	0.000611	0.00444	CcSEcCtD
Salicylic acid—Erythema—Ibandronate—osteoporosis	0.000608	0.00442	CcSEcCtD
Salicylic acid—Confusional state—Etidronic acid—osteoporosis	0.000603	0.00438	CcSEcCtD
Salicylic acid—Dizziness—Calcium Acetate—osteoporosis	0.000602	0.00438	CcSEcCtD
Salicylic acid—Asthma—Conjugated Estrogens—osteoporosis	0.000601	0.00437	CcSEcCtD
Salicylic acid—Abdominal discomfort—Zoledronate—osteoporosis	0.000598	0.00435	CcSEcCtD
Salicylic acid—Dysgeusia—Ibandronate—osteoporosis	0.000595	0.00433	CcSEcCtD
Salicylic acid—Erythema—Calcitriol—osteoporosis	0.000595	0.00433	CcSEcCtD
Salicylic acid—Dysgeusia—Calcitriol—osteoporosis	0.000582	0.00424	CcSEcCtD
Salicylic acid—Vomiting—Calcium Acetate—osteoporosis	0.000579	0.00421	CcSEcCtD
Salicylic acid—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.000576	0.00419	CcSEcCtD
Salicylic acid—Weight increased—Zoledronate—osteoporosis	0.000568	0.00413	CcSEcCtD
Salicylic acid—Lethargy—Estradiol—osteoporosis	0.000568	0.00413	CcSEcCtD
Salicylic acid—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000558	0.00406	CcSEcCtD
Salicylic acid—Weight increased—Conjugated Estrogens—osteoporosis	0.000547	0.00398	CcSEcCtD
Salicylic acid—Nausea—Calcium Acetate—osteoporosis	0.000541	0.00393	CcSEcCtD
Salicylic acid—Tinnitus—Risedronate—osteoporosis	0.000536	0.0039	CcSEcCtD
Salicylic acid—Dyspepsia—Etidronic acid—osteoporosis	0.000526	0.00383	CcSEcCtD
Salicylic acid—Oedema—Estropipate—osteoporosis	0.000517	0.00376	CcSEcCtD
Salicylic acid—Constipation—Etidronic acid—osteoporosis	0.000511	0.00372	CcSEcCtD
Salicylic acid—Abdominal pain upper—Estradiol—osteoporosis	0.000508	0.0037	CcSEcCtD
Salicylic acid—Feeling abnormal—Etidronic acid—osteoporosis	0.000492	0.00358	CcSEcCtD
Salicylic acid—Asthma—Estradiol—osteoporosis	0.000481	0.0035	CcSEcCtD
Salicylic acid—Nausea—Ergocalciferol—osteoporosis	0.000478	0.00347	CcSEcCtD
Salicylic acid—Erythema—Pamidronate—osteoporosis	0.000476	0.00346	CcSEcCtD
Salicylic acid—Urticaria—Etidronic acid—osteoporosis	0.000475	0.00345	CcSEcCtD
Salicylic acid—Dysgeusia—Pamidronate—osteoporosis	0.000466	0.00339	CcSEcCtD
Salicylic acid—Anorexia—Calcitriol—osteoporosis	0.000463	0.00337	CcSEcCtD
Salicylic acid—Abdominal discomfort—Estradiol—osteoporosis	0.000461	0.00335	CcSEcCtD
Salicylic acid—Somnolence—Estropipate—osteoporosis	0.00046	0.00334	CcSEcCtD
Salicylic acid—Dyspepsia—Estropipate—osteoporosis	0.000455	0.00331	CcSEcCtD
Salicylic acid—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000455	0.00331	CcSEcCtD
Salicylic acid—Dyspepsia—Alendronate—osteoporosis	0.000448	0.00326	CcSEcCtD
Salicylic acid—Constipation—Estropipate—osteoporosis	0.000442	0.00322	CcSEcCtD
Salicylic acid—Pain—Estropipate—osteoporosis	0.000442	0.00322	CcSEcCtD
Salicylic acid—Dyspepsia—Raloxifene—osteoporosis	0.000441	0.00321	CcSEcCtD
Salicylic acid—Weight increased—Estradiol—osteoporosis	0.000438	0.00318	CcSEcCtD
Salicylic acid—Dyspepsia—Ibandronate—osteoporosis	0.000436	0.00317	CcSEcCtD
Salicylic acid—Pain—Alendronate—osteoporosis	0.000435	0.00317	CcSEcCtD
Salicylic acid—Constipation—Alendronate—osteoporosis	0.000435	0.00317	CcSEcCtD
Salicylic acid—Erythema—Zoledronate—osteoporosis	0.000435	0.00316	CcSEcCtD
Salicylic acid—Somnolence—Calcitriol—osteoporosis	0.000431	0.00314	CcSEcCtD
Salicylic acid—Decreased appetite—Ibandronate—osteoporosis	0.000431	0.00314	CcSEcCtD
Salicylic acid—Pain—Raloxifene—osteoporosis	0.000428	0.00312	CcSEcCtD
Salicylic acid—Dysgeusia—Zoledronate—osteoporosis	0.000426	0.0031	CcSEcCtD
Salicylic acid—Pain—Ibandronate—osteoporosis	0.000424	0.00308	CcSEcCtD
Salicylic acid—Constipation—Ibandronate—osteoporosis	0.000424	0.00308	CcSEcCtD
Salicylic acid—Pruritus—Etidronic acid—osteoporosis	0.000423	0.00308	CcSEcCtD
Salicylic acid—Decreased appetite—Calcitriol—osteoporosis	0.000422	0.00307	CcSEcCtD
Salicylic acid—Feeling abnormal—Alendronate—osteoporosis	0.00042	0.00305	CcSEcCtD
Salicylic acid—Oedema—Ethinyl Estradiol—osteoporosis	0.000419	0.00305	CcSEcCtD
Salicylic acid—Erythema—Conjugated Estrogens—osteoporosis	0.000419	0.00304	CcSEcCtD
Salicylic acid—Pain—Calcitriol—osteoporosis	0.000415	0.00302	CcSEcCtD
Salicylic acid—Constipation—Calcitriol—osteoporosis	0.000415	0.00302	CcSEcCtD
Salicylic acid—Urticaria—Estropipate—osteoporosis	0.000411	0.00299	CcSEcCtD
Salicylic acid—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00041	0.00298	CcSEcCtD
Salicylic acid—Diarrhoea—Etidronic acid—osteoporosis	0.000409	0.00297	CcSEcCtD
Salicylic acid—Feeling abnormal—Ibandronate—osteoporosis	0.000409	0.00297	CcSEcCtD
Salicylic acid—Urticaria—Alendronate—osteoporosis	0.000405	0.00294	CcSEcCtD
Salicylic acid—Epistaxis—Estradiol—osteoporosis	0.000404	0.00294	CcSEcCtD
Salicylic acid—Urticaria—Ibandronate—osteoporosis	0.000394	0.00286	CcSEcCtD
Salicylic acid—Confusional state—Pamidronate—osteoporosis	0.000392	0.00285	CcSEcCtD
Salicylic acid—Oedema—Pamidronate—osteoporosis	0.000388	0.00283	CcSEcCtD
Salicylic acid—Urticaria—Calcitriol—osteoporosis	0.000386	0.0028	CcSEcCtD
Salicylic acid—Hepatitis—Estradiol—osteoporosis	0.000385	0.0028	CcSEcCtD
Salicylic acid—Vomiting—Etidronic acid—osteoporosis	0.00038	0.00276	CcSEcCtD
Salicylic acid—Rash—Etidronic acid—osteoporosis	0.000377	0.00274	CcSEcCtD
Salicylic acid—Dermatitis—Etidronic acid—osteoporosis	0.000376	0.00274	CcSEcCtD
Salicylic acid—Headache—Etidronic acid—osteoporosis	0.000374	0.00272	CcSEcCtD
Salicylic acid—Anorexia—Pamidronate—osteoporosis	0.00037	0.00269	CcSEcCtD
Salicylic acid—Pruritus—Estropipate—osteoporosis	0.000366	0.00266	CcSEcCtD
Salicylic acid—Erythema multiforme—Estradiol—osteoporosis	0.000364	0.00265	CcSEcCtD
Salicylic acid—Pruritus—Alendronate—osteoporosis	0.00036	0.00262	CcSEcCtD
Salicylic acid—Dyspepsia—Risedronate—osteoporosis	0.00036	0.00262	CcSEcCtD
Salicylic acid—Tinnitus—Estradiol—osteoporosis	0.000359	0.00261	CcSEcCtD
Salicylic acid—Constipation—Ethinyl Estradiol—osteoporosis	0.000358	0.00261	CcSEcCtD
Salicylic acid—Confusional state—Zoledronate—osteoporosis	0.000358	0.0026	CcSEcCtD
Salicylic acid—Nausea—Etidronic acid—osteoporosis	0.000355	0.00258	CcSEcCtD
Salicylic acid—Oedema—Zoledronate—osteoporosis	0.000355	0.00258	CcSEcCtD
Salicylic acid—Diarrhoea—Estropipate—osteoporosis	0.000354	0.00257	CcSEcCtD
Salicylic acid—Pruritus—Ibandronate—osteoporosis	0.000351	0.00255	CcSEcCtD
Salicylic acid—Pain—Risedronate—osteoporosis	0.000349	0.00254	CcSEcCtD
Salicylic acid—Constipation—Risedronate—osteoporosis	0.000349	0.00254	CcSEcCtD
Salicylic acid—Diarrhoea—Alendronate—osteoporosis	0.000348	0.00253	CcSEcCtD
Salicylic acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000345	0.00251	CcSEcCtD
Salicylic acid—Somnolence—Pamidronate—osteoporosis	0.000345	0.00251	CcSEcCtD
Salicylic acid—Pruritus—Calcitriol—osteoporosis	0.000343	0.0025	CcSEcCtD
Salicylic acid—Diarrhoea—Raloxifene—osteoporosis	0.000343	0.00249	CcSEcCtD
Salicylic acid—Dyspepsia—Pamidronate—osteoporosis	0.000342	0.00249	CcSEcCtD
Salicylic acid—Dizziness—Estropipate—osteoporosis	0.000342	0.00249	CcSEcCtD
Salicylic acid—Oedema—Conjugated Estrogens—osteoporosis	0.000342	0.00248	CcSEcCtD
Salicylic acid—Diarrhoea—Ibandronate—osteoporosis	0.000339	0.00247	CcSEcCtD
Salicylic acid—Anorexia—Zoledronate—osteoporosis	0.000338	0.00246	CcSEcCtD
Salicylic acid—Decreased appetite—Pamidronate—osteoporosis	0.000338	0.00246	CcSEcCtD
Salicylic acid—Dizziness—Alendronate—osteoporosis	0.000337	0.00245	CcSEcCtD
Salicylic acid—Erythema—Estradiol—osteoporosis	0.000335	0.00244	CcSEcCtD
Salicylic acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.000333	0.00242	CcSEcCtD
Salicylic acid—Pain—Pamidronate—osteoporosis	0.000332	0.00242	CcSEcCtD
Salicylic acid—Constipation—Pamidronate—osteoporosis	0.000332	0.00242	CcSEcCtD
Salicylic acid—Diarrhoea—Calcitriol—osteoporosis	0.000332	0.00242	CcSEcCtD
Salicylic acid—Dizziness—Raloxifene—osteoporosis	0.000331	0.00241	CcSEcCtD
Salicylic acid—Vomiting—Estropipate—osteoporosis	0.000329	0.00239	CcSEcCtD
Salicylic acid—Dysgeusia—Estradiol—osteoporosis	0.000328	0.00239	CcSEcCtD
Salicylic acid—Dizziness—Ibandronate—osteoporosis	0.000328	0.00238	CcSEcCtD
Salicylic acid—Rash—Estropipate—osteoporosis	0.000326	0.00237	CcSEcCtD
Salicylic acid—Dermatitis—Estropipate—osteoporosis	0.000326	0.00237	CcSEcCtD
Salicylic acid—Anorexia—Conjugated Estrogens—osteoporosis	0.000326	0.00237	CcSEcCtD
Salicylic acid—Urticaria—Risedronate—osteoporosis	0.000325	0.00236	CcSEcCtD
Salicylic acid—Headache—Estropipate—osteoporosis	0.000324	0.00236	CcSEcCtD
Salicylic acid—Vomiting—Alendronate—osteoporosis	0.000324	0.00236	CcSEcCtD
Salicylic acid—Rash—Alendronate—osteoporosis	0.000321	0.00234	CcSEcCtD
Salicylic acid—Dermatitis—Alendronate—osteoporosis	0.000321	0.00233	CcSEcCtD
Salicylic acid—Feeling abnormal—Pamidronate—osteoporosis	0.00032	0.00233	CcSEcCtD
Salicylic acid—Headache—Alendronate—osteoporosis	0.000319	0.00232	CcSEcCtD
Salicylic acid—Vomiting—Raloxifene—osteoporosis	0.000318	0.00232	CcSEcCtD
Salicylic acid—Rash—Raloxifene—osteoporosis	0.000316	0.0023	CcSEcCtD
Salicylic acid—Dermatitis—Raloxifene—osteoporosis	0.000315	0.00229	CcSEcCtD
Salicylic acid—Somnolence—Zoledronate—osteoporosis	0.000315	0.00229	CcSEcCtD
Salicylic acid—Vomiting—Ibandronate—osteoporosis	0.000315	0.00229	CcSEcCtD
Salicylic acid—Headache—Raloxifene—osteoporosis	0.000314	0.00228	CcSEcCtD
Salicylic acid—Rash—Ibandronate—osteoporosis	0.000313	0.00227	CcSEcCtD
Salicylic acid—Dermatitis—Ibandronate—osteoporosis	0.000312	0.00227	CcSEcCtD
Salicylic acid—Dyspepsia—Zoledronate—osteoporosis	0.000312	0.00227	CcSEcCtD
Salicylic acid—Headache—Ibandronate—osteoporosis	0.000311	0.00226	CcSEcCtD
Salicylic acid—Vomiting—Calcitriol—osteoporosis	0.000309	0.00224	CcSEcCtD
Salicylic acid—Decreased appetite—Zoledronate—osteoporosis	0.000308	0.00224	CcSEcCtD
Salicylic acid—Nausea—Estropipate—osteoporosis	0.000307	0.00223	CcSEcCtD
Salicylic acid—Rash—Calcitriol—osteoporosis	0.000306	0.00223	CcSEcCtD
Salicylic acid—Dermatitis—Calcitriol—osteoporosis	0.000306	0.00222	CcSEcCtD
Salicylic acid—Headache—Calcitriol—osteoporosis	0.000304	0.00221	CcSEcCtD
Salicylic acid—Somnolence—Conjugated Estrogens—osteoporosis	0.000304	0.00221	CcSEcCtD
Salicylic acid—Constipation—Zoledronate—osteoporosis	0.000303	0.00221	CcSEcCtD
Salicylic acid—Pain—Zoledronate—osteoporosis	0.000303	0.00221	CcSEcCtD
Salicylic acid—Nausea—Alendronate—osteoporosis	0.000302	0.0022	CcSEcCtD
Salicylic acid—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000301	0.00219	CcSEcCtD
Salicylic acid—Nausea—Raloxifene—osteoporosis	0.000297	0.00216	CcSEcCtD
Salicylic acid—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000297	0.00216	CcSEcCtD
Salicylic acid—Pruritus—Ethinyl Estradiol—osteoporosis	0.000297	0.00216	CcSEcCtD
Salicylic acid—Nausea—Ibandronate—osteoporosis	0.000295	0.00214	CcSEcCtD
Salicylic acid—Feeling abnormal—Zoledronate—osteoporosis	0.000292	0.00213	CcSEcCtD
Salicylic acid—Constipation—Conjugated Estrogens—osteoporosis	0.000292	0.00213	CcSEcCtD
Salicylic acid—Pain—Conjugated Estrogens—osteoporosis	0.000292	0.00213	CcSEcCtD
Salicylic acid—Pruritus—Risedronate—osteoporosis	0.000289	0.0021	CcSEcCtD
Salicylic acid—Nausea—Calcitriol—osteoporosis	0.000288	0.0021	CcSEcCtD
Salicylic acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000287	0.00209	CcSEcCtD
Salicylic acid—Urticaria—Zoledronate—osteoporosis	0.000282	0.00205	CcSEcCtD
Salicylic acid—Diarrhoea—Risedronate—osteoporosis	0.00028	0.00203	CcSEcCtD
Salicylic acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.000277	0.00202	CcSEcCtD
Salicylic acid—Confusional state—Estradiol—osteoporosis	0.000276	0.00201	CcSEcCtD
Salicylic acid—Pruritus—Pamidronate—osteoporosis	0.000275	0.002	CcSEcCtD
Salicylic acid—Oedema—Estradiol—osteoporosis	0.000273	0.00199	CcSEcCtD
Salicylic acid—Urticaria—Conjugated Estrogens—osteoporosis	0.000271	0.00197	CcSEcCtD
Salicylic acid—Dizziness—Risedronate—osteoporosis	0.00027	0.00197	CcSEcCtD
Salicylic acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000266	0.00194	CcSEcCtD
Salicylic acid—Diarrhoea—Pamidronate—osteoporosis	0.000266	0.00193	CcSEcCtD
Salicylic acid—Rash—Ethinyl Estradiol—osteoporosis	0.000264	0.00192	CcSEcCtD
Salicylic acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000264	0.00192	CcSEcCtD
Salicylic acid—Headache—Ethinyl Estradiol—osteoporosis	0.000263	0.00191	CcSEcCtD
Salicylic acid—Vomiting—Risedronate—osteoporosis	0.00026	0.00189	CcSEcCtD
Salicylic acid—Rash—Risedronate—osteoporosis	0.000258	0.00187	CcSEcCtD
Salicylic acid—Dermatitis—Risedronate—osteoporosis	0.000257	0.00187	CcSEcCtD
Salicylic acid—Dizziness—Pamidronate—osteoporosis	0.000257	0.00187	CcSEcCtD
Salicylic acid—Headache—Risedronate—osteoporosis	0.000256	0.00186	CcSEcCtD
Salicylic acid—Pruritus—Zoledronate—osteoporosis	0.000251	0.00183	CcSEcCtD
Salicylic acid—Nausea—Ethinyl Estradiol—osteoporosis	0.000249	0.00181	CcSEcCtD
Salicylic acid—Vomiting—Pamidronate—osteoporosis	0.000247	0.0018	CcSEcCtD
Salicylic acid—Rash—Pamidronate—osteoporosis	0.000245	0.00178	CcSEcCtD
Salicylic acid—Dermatitis—Pamidronate—osteoporosis	0.000245	0.00178	CcSEcCtD
Salicylic acid—Headache—Pamidronate—osteoporosis	0.000243	0.00177	CcSEcCtD
Salicylic acid—Somnolence—Estradiol—osteoporosis	0.000243	0.00177	CcSEcCtD
Salicylic acid—Diarrhoea—Zoledronate—osteoporosis	0.000243	0.00177	CcSEcCtD
Salicylic acid—Nausea—Risedronate—osteoporosis	0.000243	0.00177	CcSEcCtD
Salicylic acid—Pruritus—Conjugated Estrogens—osteoporosis	0.000242	0.00176	CcSEcCtD
Salicylic acid—Dyspepsia—Estradiol—osteoporosis	0.000241	0.00175	CcSEcCtD
Salicylic acid—Decreased appetite—Estradiol—osteoporosis	0.000238	0.00173	CcSEcCtD
Salicylic acid—Dizziness—Zoledronate—osteoporosis	0.000235	0.00171	CcSEcCtD
Salicylic acid—Pain—Estradiol—osteoporosis	0.000234	0.0017	CcSEcCtD
Salicylic acid—Constipation—Estradiol—osteoporosis	0.000234	0.0017	CcSEcCtD
Salicylic acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000234	0.0017	CcSEcCtD
Salicylic acid—Nausea—Pamidronate—osteoporosis	0.000231	0.00168	CcSEcCtD
Salicylic acid—Dizziness—Conjugated Estrogens—osteoporosis	0.000226	0.00164	CcSEcCtD
Salicylic acid—Vomiting—Zoledronate—osteoporosis	0.000226	0.00164	CcSEcCtD
Salicylic acid—Feeling abnormal—Estradiol—osteoporosis	0.000225	0.00164	CcSEcCtD
Salicylic acid—Rash—Zoledronate—osteoporosis	0.000224	0.00163	CcSEcCtD
Salicylic acid—Dermatitis—Zoledronate—osteoporosis	0.000224	0.00163	CcSEcCtD
Salicylic acid—Headache—Zoledronate—osteoporosis	0.000222	0.00162	CcSEcCtD
Salicylic acid—Vomiting—Conjugated Estrogens—osteoporosis	0.000217	0.00158	CcSEcCtD
Salicylic acid—Urticaria—Estradiol—osteoporosis	0.000217	0.00158	CcSEcCtD
Salicylic acid—Rash—Conjugated Estrogens—osteoporosis	0.000215	0.00157	CcSEcCtD
Salicylic acid—Dermatitis—Conjugated Estrogens—osteoporosis	0.000215	0.00157	CcSEcCtD
Salicylic acid—Headache—Conjugated Estrogens—osteoporosis	0.000214	0.00156	CcSEcCtD
Salicylic acid—Nausea—Zoledronate—osteoporosis	0.000211	0.00153	CcSEcCtD
Salicylic acid—Nausea—Conjugated Estrogens—osteoporosis	0.000203	0.00148	CcSEcCtD
Salicylic acid—Pruritus—Estradiol—osteoporosis	0.000193	0.00141	CcSEcCtD
Salicylic acid—Diarrhoea—Estradiol—osteoporosis	0.000187	0.00136	CcSEcCtD
Salicylic acid—Dizziness—Estradiol—osteoporosis	0.000181	0.00132	CcSEcCtD
Salicylic acid—Vomiting—Estradiol—osteoporosis	0.000174	0.00126	CcSEcCtD
Salicylic acid—Rash—Estradiol—osteoporosis	0.000172	0.00125	CcSEcCtD
Salicylic acid—Dermatitis—Estradiol—osteoporosis	0.000172	0.00125	CcSEcCtD
Salicylic acid—Headache—Estradiol—osteoporosis	0.000171	0.00125	CcSEcCtD
Salicylic acid—Nausea—Estradiol—osteoporosis	0.000162	0.00118	CcSEcCtD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	4.74e-05	0.000805	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—P4HB—osteoporosis	4.68e-05	0.000795	CbGpPWpGaD
Salicylic acid—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	4.67e-05	0.000793	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.67e-05	0.000793	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MTHFR—osteoporosis	4.65e-05	0.00079	CbGpPWpGaD
Salicylic acid—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	4.61e-05	0.000782	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GAPDH—osteoporosis	4.59e-05	0.00078	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.54e-05	0.000771	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ANTXR2—osteoporosis	4.52e-05	0.000768	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PGLS—osteoporosis	4.52e-05	0.000768	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KL—osteoporosis	4.52e-05	0.000768	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TLN1—osteoporosis	4.52e-05	0.000767	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—RAP1A—osteoporosis	4.47e-05	0.00076	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VCL—osteoporosis	4.46e-05	0.000757	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IRS2—osteoporosis	4.43e-05	0.000752	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.38e-05	0.000744	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.38e-05	0.000744	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ATIC—osteoporosis	4.37e-05	0.000741	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PNP—osteoporosis	4.37e-05	0.000741	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	4.35e-05	0.000739	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	4.35e-05	0.000738	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.33e-05	0.000736	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.27e-05	0.000725	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	4.25e-05	0.000722	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—ADCY5—osteoporosis	4.24e-05	0.00072	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—GPX1—osteoporosis	4.22e-05	0.000717	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.17e-05	0.000708	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.15e-05	0.000706	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IGF1—osteoporosis	4.12e-05	0.0007	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—FDPS—osteoporosis	4e-05	0.000679	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PKM—osteoporosis	4e-05	0.000679	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.97e-05	0.000675	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—osteoporosis	3.97e-05	0.000675	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	3.97e-05	0.000673	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.94e-05	0.000669	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.92e-05	0.000666	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	3.9e-05	0.000663	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—MTHFR—osteoporosis	3.9e-05	0.000662	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IRS1—osteoporosis	3.86e-05	0.000656	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GSN—osteoporosis	3.85e-05	0.000653	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PGLS—osteoporosis	3.79e-05	0.000644	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPD2—osteoporosis	3.79e-05	0.000644	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.75e-05	0.000637	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAP1A—osteoporosis	3.72e-05	0.000632	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—OXCT1—osteoporosis	3.71e-05	0.00063	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CA2—osteoporosis	3.71e-05	0.00063	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—TGFB1—osteoporosis	3.65e-05	0.000619	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6R—osteoporosis	3.63e-05	0.000617	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ENO1—osteoporosis	3.62e-05	0.000614	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MGLL—osteoporosis	3.62e-05	0.000614	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PSMA5—osteoporosis	3.56e-05	0.000605	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PSMA2—osteoporosis	3.56e-05	0.000605	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.55e-05	0.000602	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ADCY5—osteoporosis	3.54e-05	0.000602	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.47e-05	0.00059	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PNP—osteoporosis	3.47e-05	0.000589	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ATIC—osteoporosis	3.47e-05	0.000589	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SPP1—osteoporosis	3.43e-05	0.000582	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.41e-05	0.00058	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.41e-05	0.000579	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—FGA—osteoporosis	3.38e-05	0.000574	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LRP5—osteoporosis	3.35e-05	0.000568	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MYC—osteoporosis	3.31e-05	0.000562	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	3.3e-05	0.000561	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.27e-05	0.000556	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PKM—osteoporosis	3.23e-05	0.000549	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—FDPS—osteoporosis	3.23e-05	0.000549	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.23e-05	0.000548	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL6—osteoporosis	3.21e-05	0.000544	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LRP6—osteoporosis	3.2e-05	0.000544	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.16e-05	0.000536	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	3.15e-05	0.000535	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—POMC—osteoporosis	3.12e-05	0.000529	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IRS2—osteoporosis	3.1e-05	0.000527	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—osteoporosis	3.08e-05	0.000524	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—IDH2—osteoporosis	3.08e-05	0.000522	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LTF—osteoporosis	3.08e-05	0.000522	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RPL24—osteoporosis	3.08e-05	0.000522	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—FGB—osteoporosis	3.07e-05	0.000522	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.07e-05	0.000521	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PGLS—osteoporosis	3.07e-05	0.000521	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPD2—osteoporosis	3.07e-05	0.000521	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—LEP—osteoporosis	3.03e-05	0.000515	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—osteoporosis	3.01e-05	0.000512	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CA2—osteoporosis	2.95e-05	0.0005	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—OXCT1—osteoporosis	2.95e-05	0.0005	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.9e-05	0.000493	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ESR1—osteoporosis	2.9e-05	0.000492	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CYP19A1—osteoporosis	2.89e-05	0.000491	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP27A1—osteoporosis	2.89e-05	0.000491	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MGLL—osteoporosis	2.87e-05	0.000488	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PKM—osteoporosis	2.83e-05	0.000481	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FDPS—osteoporosis	2.83e-05	0.000481	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ACP5—osteoporosis	2.81e-05	0.000478	CbGpPWpGaD
Salicylic acid—CYP2C9—Biological oxidations—POMC—osteoporosis	2.81e-05	0.000477	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PNP—osteoporosis	2.8e-05	0.000476	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ATIC—osteoporosis	2.8e-05	0.000476	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.78e-05	0.000472	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.71e-05	0.00046	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IRS1—osteoporosis	2.71e-05	0.00046	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.7e-05	0.000458	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PGLS—osteoporosis	2.69e-05	0.000456	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPD2—osteoporosis	2.69e-05	0.000456	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ACP5—osteoporosis	2.67e-05	0.000453	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.66e-05	0.000451	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PKM—osteoporosis	2.65e-05	0.00045	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FDPS—osteoporosis	2.65e-05	0.00045	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TPI1—osteoporosis	2.62e-05	0.000444	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—POMC—osteoporosis	2.61e-05	0.000443	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.55e-05	0.000433	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6R—osteoporosis	2.54e-05	0.000432	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PGLS—osteoporosis	2.51e-05	0.000426	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPD2—osteoporosis	2.51e-05	0.000426	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IGF1—osteoporosis	2.51e-05	0.000426	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—osteoporosis	2.49e-05	0.000423	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TPI1—osteoporosis	2.48e-05	0.000421	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TGFB1—osteoporosis	2.47e-05	0.00042	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—P4HB—osteoporosis	2.46e-05	0.000418	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PNP—osteoporosis	2.46e-05	0.000417	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ATIC—osteoporosis	2.46e-05	0.000417	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—IDH2—osteoporosis	2.44e-05	0.000415	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GAPDH—osteoporosis	2.41e-05	0.00041	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CA2—osteoporosis	2.38e-05	0.000405	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—OXCT1—osteoporosis	2.38e-05	0.000405	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ADCY5—osteoporosis	2.36e-05	0.000401	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GPX1—osteoporosis	2.35e-05	0.0004	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—RAP1A—osteoporosis	2.35e-05	0.000399	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—P4HB—osteoporosis	2.33e-05	0.000396	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MGLL—osteoporosis	2.32e-05	0.000395	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP27A1—osteoporosis	2.3e-05	0.00039	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ATIC—osteoporosis	2.29e-05	0.00039	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PNP—osteoporosis	2.29e-05	0.00039	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GAPDH—osteoporosis	2.29e-05	0.000389	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.25e-05	0.000383	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.25e-05	0.000382	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ACP5—osteoporosis	2.23e-05	0.000379	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.2e-05	0.000374	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.19e-05	0.000372	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NFATC1—osteoporosis	2.17e-05	0.000369	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—MTHFR—osteoporosis	2.17e-05	0.000369	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—DKK1—osteoporosis	2.16e-05	0.000366	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—osteoporosis	2.15e-05	0.000365	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TGFB1—osteoporosis	2.15e-05	0.000365	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.1e-05	0.000356	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CA2—osteoporosis	2.09e-05	0.000355	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—OXCT1—osteoporosis	2.09e-05	0.000355	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—WNT1—osteoporosis	2.08e-05	0.000353	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TPI1—osteoporosis	2.08e-05	0.000353	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.05e-05	0.000348	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MGLL—osteoporosis	2.04e-05	0.000346	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGA—osteoporosis	2.02e-05	0.000343	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—IDH2—osteoporosis	1.98e-05	0.000336	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—P4HB—osteoporosis	1.95e-05	0.000332	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CA2—osteoporosis	1.95e-05	0.000331	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—OXCT1—osteoporosis	1.95e-05	0.000331	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GAPDH—osteoporosis	1.92e-05	0.000325	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MGLL—osteoporosis	1.9e-05	0.000323	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ENO1—osteoporosis	1.9e-05	0.000323	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSMA2—osteoporosis	1.87e-05	0.000318	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSMA5—osteoporosis	1.87e-05	0.000318	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—RAP1A—osteoporosis	1.87e-05	0.000317	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.000315	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ACP5—osteoporosis	1.81e-05	0.000307	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ENO1—osteoporosis	1.8e-05	0.000306	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.79e-05	0.000305	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.78e-05	0.000303	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSMA2—osteoporosis	1.77e-05	0.000301	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSMA5—osteoporosis	1.77e-05	0.000301	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—POMC—osteoporosis	1.74e-05	0.000295	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—IDH2—osteoporosis	1.73e-05	0.000294	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.7e-05	0.000289	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TPI1—osteoporosis	1.68e-05	0.000285	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CALCA—osteoporosis	1.65e-05	0.000281	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.63e-05	0.000276	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000276	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.62e-05	0.000275	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—osteoporosis	1.62e-05	0.000275	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—IDH2—osteoporosis	1.62e-05	0.000275	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.6e-05	0.000271	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.59e-05	0.000271	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ACP5—osteoporosis	1.58e-05	0.000269	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—P4HB—osteoporosis	1.58e-05	0.000268	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GAPDH—osteoporosis	1.55e-05	0.000263	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.52e-05	0.000258	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP19A1—osteoporosis	1.52e-05	0.000258	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—RAP1A—osteoporosis	1.51e-05	0.000256	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ENO1—osteoporosis	1.51e-05	0.000256	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—osteoporosis	1.51e-05	0.000256	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TGFB1—osteoporosis	1.5e-05	0.000255	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KL—osteoporosis	1.5e-05	0.000255	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.49e-05	0.000253	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.49e-05	0.000253	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000252	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000252	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ACP5—osteoporosis	1.48e-05	0.000251	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TPI1—osteoporosis	1.47e-05	0.00025	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.46e-05	0.000248	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF1—osteoporosis	1.39e-05	0.000236	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—P4HB—osteoporosis	1.38e-05	0.000235	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TPI1—osteoporosis	1.37e-05	0.000234	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000231	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000225	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.32e-05	0.000224	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—P4HB—osteoporosis	1.29e-05	0.00022	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000215	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ADCY5—osteoporosis	1.24e-05	0.000211	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPX1—osteoporosis	1.24e-05	0.00021	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—RAP1A—osteoporosis	1.24e-05	0.00021	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO1—osteoporosis	1.22e-05	0.000207	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000205	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSMA5—osteoporosis	1.2e-05	0.000204	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSMA2—osteoporosis	1.2e-05	0.000204	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ADCY5—osteoporosis	1.18e-05	0.0002	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MTHFR—osteoporosis	1.14e-05	0.000194	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—osteoporosis	1.13e-05	0.000192	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTHFR—osteoporosis	1.08e-05	0.000184	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.08e-05	0.000183	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO1—osteoporosis	1.07e-05	0.000182	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000179	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000179	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IRS2—osteoporosis	1.03e-05	0.000175	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO1—osteoporosis	9.99e-06	0.00017	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ADCY5—osteoporosis	9.85e-06	0.000167	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSMA2—osteoporosis	9.84e-06	0.000167	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSMA5—osteoporosis	9.84e-06	0.000167	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPX1—osteoporosis	9.82e-06	0.000167	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP19A1—osteoporosis	9.76e-06	0.000166	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—POMC—osteoporosis	9.13e-06	0.000155	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MTHFR—osteoporosis	9.06e-06	0.000154	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IRS1—osteoporosis	8.99e-06	0.000153	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP19A1—osteoporosis	8.55e-06	0.000145	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6R—osteoporosis	8.44e-06	0.000143	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TGFB1—osteoporosis	8.34e-06	0.000142	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.99e-06	0.000136	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ADCY5—osteoporosis	7.97e-06	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPX1—osteoporosis	7.94e-06	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MTHFR—osteoporosis	7.33e-06	0.000125	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—POMC—osteoporosis	7.25e-06	0.000123	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ADCY5—osteoporosis	6.98e-06	0.000119	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPX1—osteoporosis	6.96e-06	0.000118	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ADCY5—osteoporosis	6.52e-06	0.000111	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPX1—osteoporosis	6.5e-06	0.00011	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MTHFR—osteoporosis	6.42e-06	0.000109	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MTHFR—osteoporosis	6e-06	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—POMC—osteoporosis	5.86e-06	9.96e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—POMC—osteoporosis	5.14e-06	8.73e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—osteoporosis	5e-06	8.5e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFB1—osteoporosis	4.99e-06	8.48e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—POMC—osteoporosis	4.8e-06	8.15e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—osteoporosis	3.76e-06	6.39e-05	CbGpPWpGaD
